What does complement do in Alzheimer's disease? Old molecules with new insights.
Yong Shen1, Libang Yang, Rena Li
1Center for Advanced Therapeutic Strategies for Brain Disorders, Roskamp Institute, 2040 Whitfield Avenue, Sarasota, USA. yshen@rfdn.org.
Alzheimer's disease involves brain inflammation and immune responses. Complement activation in the brain contributes to inflammation and cognitive decline, highlighting its complex role in Alzheimer's disease pathology.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Alzheimer's disease (AD) pathogenesis is increasingly linked to neuroinflammation and immune system dysregulation.
- Complement activation within the brain is a known factor in AD, correlating with cognitive impairment.
- The complement system plays a dual role: protecting the host while also potentially causing inflammation and cell damage.
Purpose of the Study:
- To review the molecular interactions within the brain during Alzheimer's disease development.
- To elucidate the functional outcomes of these molecular interactions.
- To detail the contribution of individual elements to AD pathogenesis.
Main Methods:
- Mini-review of existing literature on Alzheimer's disease, neuroinflammation, and the complement system.
- Analysis of molecular interactions and their functional consequences in AD.
- Synthesis of information on the role of complement in AD pathology.
Main Results:
- Complement activation in AD brains contributes to local inflammation and cognitive deficits.
- Complement proteins mediate both protective immune functions and inflammatory damage.
- The balance of complement-mediated events critically influences neuronal function in AD.
Conclusions:
- Understanding the complex role of complement activation is crucial for developing targeted therapies for Alzheimer's disease.
- Anti-inflammatory and immunotherapeutic strategies targeting the complement system show promise for AD treatment.
- Further research into the intricate molecular interplay in AD is warranted.
More Related Videos
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer Disease ll: Pathophysiology
Alzheimer Disease l: Introduction
Alzheimer's Disease: Treatment
Complement System
Dementia l: Introduction
